We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BioLineRx Ltd. (BLRX) - free report >>
Marinus Pharmaceuticals, Inc. (MRNS) - free report >>
ASLAN Pharmaceuticals Ltd. (ASLN) - free report >>
Investcorp Credit Management BDC, Inc. (ICMB) - free report >>
Image: Bigstock
New Strong Sell Stocks for June 4th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
ASLAN Pharmaceuticals Limited (ASLN - Free Report) operates as a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 30 days.
BioLineRx Ltd. is a biopharmaceutical development company. The Zacks Consensus Estimate for its current year earnings has been revised 17.7% downward over the last 30 days.
Flexion Therapeutics, Inc. is a specialty pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.
Investcorp Credit Management BDC, Inc. (ICMB - Free Report) is a business development company. The Zacks Consensus Estimate for its current year earnings has been revised 15.9% downward over the last 30 days.
Marinus Pharmaceuticals, Inc. (MRNS - Free Report) is a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 38.5% downward over the last 30 days.
View the entire Zacks Rank #5 List.